Invention Grant
US09120811B2 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma
有权
用于治疗白血病或淋巴瘤的6-（1H-吲唑-6-基）-N-（4-吗啉代苯基）咪唑并[1,4-A]吡嗪-8-胺
![6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma](/docs/US/2015-09-01/US09120811B2/abs.jpg.600x600.jpg)
- Patent Title: 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma
- Patent Title (中): 用于治疗白血病或淋巴瘤的6-（1H-吲唑-6-基）-N-（4-吗啉代苯基）咪唑并[1,4-A]吡嗪-8-胺
-
Application No.: US14274618Application Date: 2014-05-09
-
Publication No.: US09120811B2Publication Date: 2015-09-01
- Inventor: Scott A. Mitchell , Kevin S. Currie
- Applicant: Gilead Connecticut, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Connecticut, Inc.
- Current Assignee: Gilead Connecticut, Inc.
- Current Assignee Address: US CA Foster City
- Agent Steven R. Eck
- Main IPC: C07D231/56
- IPC: C07D231/56 ; C07D413/14 ; C07D487/04 ; C07D498/04 ; A61K31/495 ; C07D519/00 ; C12Q1/48 ; C07D471/04 ; C07D491/107 ; G01N33/573
![6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma](/abs-image/US/2015/09/01/US09120811B2/abs.jpg.150x150.jpg)
Abstract:
Provided are imidazopyrazine compounds, including 6-(1H-indazol-6-yl)-N-(4 -moirpholinophenyl)imidazo-[1,2-a]pyrazine-8-amine: and methods for using the imidazopyrazine compounds for treating diseases and disorders responsive to the inhibition of Syk activity, including leukemia and lymphoma.
Public/Granted literature
- US20140336169A1 IMIDAZOPYRAZINE SYK INHIBITORS Public/Granted day:2014-11-13
Information query
